lobbying_activities: 828890

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
828890	df2be76a-ebde-4ad5-8126-b9dcb7389619	Q3	AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS	3457	AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS	2009	third_quarter	PHA	Meeting with FDA relating to removal of unapproved products, opportunities for future collaboration; Risk Evaluation and Mitigation Strategies. Meeting with FDA regarding design and use of NDC number.	Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,White House Office		250000	0	0	2009-10-15T12:33:24-04:00